Literature DB >> 32319194

Bayesian accrual modeling and prediction in multicenter clinical trials with varying center activation times.

Junhao Liu1,2, Jo Wick1, Yu Jiang3, Matthew Mayo1, Byron Gajewski1.   

Abstract

Investigators who manage multicenter clinical trials need to pay careful attention to patterns of subject accrual, and the prediction of activation time for pending centers is potentially crucial for subject accrual prediction. We propose a Bayesian hierarchical model to predict subject accrual for multicenter clinical trials in which center activation times vary. We define center activation time as the time at which a center can begin enrolling patients in the trial. The difference in activation times between centers is assumed to follow an exponential distribution, and the model of subject accrual integrates prior information for the study with actual enrollment progress. We apply our proposed Bayesian multicenter accrual model to two multicenter clinical studies. The first is the PAIN-CONTRoLS study, a multicenter clinical trial with a goal of activating 40 centers and enrolling 400 patients within 104 weeks. The second is the HOBIT trial, a multicenter clinical trial with a goal of activating 14 centers and enrolling 200 subjects within 36 months. In summary, the Bayesian multicenter accrual model provides a prediction of subject accrual while accounting for both center- and individual patient-level variation.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  Bayesian model; center activation time; centers decision; multicenter clinical trials

Mesh:

Year:  2020        PMID: 32319194      PMCID: PMC7529726          DOI: 10.1002/pst.2025

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  18 in total

1.  Design of multi-centre trials with binary response.

Authors:  Vladimir Dragalin; Valerii Fedorov
Journal:  Stat Med       Date:  2006-08-30       Impact factor: 2.373

2.  Predicting accrual in clinical trials with Bayesian posterior predictive distributions.

Authors:  Byron J Gajewski; Stephen D Simon; Susan E Carlson
Journal:  Stat Med       Date:  2008-06-15       Impact factor: 2.373

Review 3.  Real-time prediction of clinical trial enrollment and event counts: A review.

Authors:  Daniel F Heitjan; Zhiyun Ge; Gui-Shuang Ying
Journal:  Contemp Clin Trials       Date:  2015-07-16       Impact factor: 2.226

4.  Prevalence, characteristics, and publication of discontinued randomized trials.

Authors:  Benjamin Kasenda; Erik von Elm; John You; Anette Blümle; Yuki Tomonaga; Ramon Saccilotto; Alain Amstutz; Theresa Bengough; Joerg J Meerpohl; Mihaela Stegert; Kari A O Tikkinen; Ignacio Neumann; Alonso Carrasco-Labra; Markus Faulhaber; Sohail M Mulla; Dominik Mertz; Elie A Akl; Dirk Bassler; Jason W Busse; Ignacio Ferreira-González; Francois Lamontagne; Alain Nordmann; Viktoria Gloy; Heike Raatz; Lorenzo Moja; Rachel Rosenthal; Shanil Ebrahim; Stefan Schandelmaier; Sun Xin; Per O Vandvik; Bradley C Johnston; Martin A Walter; Bernard Burnand; Matthias Schwenkglenks; Lars G Hemkens; Heiner C Bucher; Gordon H Guyatt; Matthias Briel
Journal:  JAMA       Date:  2014-03-12       Impact factor: 56.272

5.  Accrual Prediction Program: A web-based clinical trials tool for monitoring and predicting accrual for early-phase cancer studies.

Authors:  Junhao Liu; Jo A Wick; Dinesh Pal Mudaranthakam; Yu Jiang; Matthew S Mayo; Byron J Gajewski
Journal:  Clin Trials       Date:  2019-08-26       Impact factor: 2.486

6.  Bayesian hierarchical EMAX model for dose-response in early phase efficacy clinical trials.

Authors:  Byron J Gajewski; Caitlyn Meinzer; Scott M Berry; Gaylan L Rockswold; William G Barsan; Frederick K Korley; Renee' H Martin
Journal:  Stat Med       Date:  2019-05-09       Impact factor: 2.373

7.  On the Existence of Constant Accrual Rates in Clinical Trials and Direction for Future Research.

Authors:  Byron J Gajewski; Stephen D Simon; Susan E Carlson
Journal:  Int J Stat Probab       Date:  2012-11-01

8.  Modelling, prediction and adaptive adjustment of recruitment in multicentre trials.

Authors:  Vladimir V Anisimov; Valerii V Fedorov
Journal:  Stat Med       Date:  2007-11-30       Impact factor: 2.373

9.  Bayesian accrual prediction for interim review of clinical studies: open source R package and smartphone application.

Authors:  Yu Jiang; Peter Guarino; Shuangge Ma; Steve Simon; Matthew S Mayo; Rama Raghavan; Byron J Gajewski
Journal:  Trials       Date:  2016-07-22       Impact factor: 2.279

10.  A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.

Authors:  Alexandra R Brown; Byron J Gajewski; Lauren S Aaronson; Dinesh Pal Mudaranthakam; Suzanne L Hunt; Scott M Berry; Melanie Quintana; Mamatha Pasnoor; Mazen M Dimachkie; Omar Jawdat; Laura Herbelin; Richard J Barohn
Journal:  Trials       Date:  2016-08-31       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.